Based on our predictions, inflammatory and immune processes, along with Immunoinflammatory signaling pathways such as IL-17, TNF, chemokine, and Toll-like receptor, may represent potential mechanisms underlying the co-morbidity of T2DM with UC. The gene discussed is IL17A; the disease is type 2 diabetes mellitus.